Oral Superoxide Dismutase (GLISODin) to Decrease Melasma Severity.

Summary

Oxidative stress has been reported to play a role in melasma pathophysiology. The objective of the study is to compare oral superoxide dismutase (GLISODin) to placebo, in combination to sunscreen to decrease melasma severity.

Timeline

Start

2019-04-01

Primary completion

2020-01-01

Completion

2020-07-01

Drugs

Indications